首页> 外文期刊>International Journal of Pharmaceutics >Establishment of new preparation method for solid dispersion formulation of tacrolimus.
【24h】

Establishment of new preparation method for solid dispersion formulation of tacrolimus.

机译:他克莫司固体分散体制剂新制备方法的建立。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to establish a new preparation method for solid dispersion formulation (SDF) of tacrolimus, a poorly water-soluble drug, without dichloromethane, because no use of dichloromethane is recommended by ICH harmonized tripartite guideline. To select the appropriate carrier, three different SDFs with polyethylene glycol 6000 (PEG 6000), polyvinylpyrrolidone (PVP) and hydroxypropylmethylcellulose (HPMC) were prepared by the conventional solvent method, in which tacrolimus and the carrier were completely dissolved in the mixture of dichloromethane and ethanol. Powder X-ray diffraction (XRD) and differential scanning calorimetry (DSC) patterns indicated that tacrolimus exists in an amorphous state in all three SDFs. The supersaturated dissolution profiles of tacrolimus were observed in all SDFs, and the highest level of supersaturation for tacrolimus was obtained and maintained for 24h from SDF with HPMC. On the other hand, the supersaturated level from SDF with PEG 6000 or PVP decreased rapidly. The in vivo oral absorption study in dogs showed that bioavailability of tacrolimus from SDF with HPMC was remarkably improved compared with the crystalline powder. It was clarified that HPMC is the most appropriate carrier for SDF of tacrolimus. Then, SDF of tacrolimus was prepared by the new method, which allows us to make SDF of tacrolimus by swelling HPMC with ethanol, in which tacrolimus was completely dissolved. This new method does not need dichloromethane. The physicochemical properties of SDF with HPMC prepared by the new method were the same as those of SDF prepared by the conventional solvent method. Furthermore, SDF with HPMC prepared by the new method was still stable after stored at 40 degrees C for 3 months. The pharmacokinetic parameters after oral administration in monkeys showed no significant difference (P>0.01) between SDFs with HPMC prepared by the two methods. In conclusion, we have established the new preparation method for SDF of tacrolimus with HPMC and the new method makes it possible to prepare SDF of tacroliumus without dichloromethane.
机译:这项研究的目的是建立一种新的他克莫司固体分散制剂(SDF)的制备方法,他克莫司是一种水溶性较差的药物,不含二氯甲烷,因为ICH协调的三方指南不建议使用二氯甲烷。为了选择合适的载体,通过常规溶剂法制备了三种不同的SDF,包括聚乙二醇6000(PEG 6000),聚乙烯吡咯烷酮(PVP)和羟丙基甲基纤维素(HPMC),其中将他克莫司和载体完全溶解在二氯甲烷和二氯甲烷的混合物中。乙醇。粉末X射线衍射(XRD)和差示扫描量热法(DSC)图谱表明,他克莫司在所有三个SDF中均以非晶态存在。在所有SDF中都观察到了他克莫司的过饱和溶解曲线,并获得了他克莫司的最高过饱和度,并用HPMC从SDF中保持了24小时。另一方面,来自SDF的PEG 6000或PVP的过饱和水平迅速下降。狗体内口服吸收研究表明,与结晶性粉末相比,HPD与SDF联合使用他克莫司的生物利用度显着提高。明确了HPMC是他克莫司SDF最合适的载体。然后,通过新方法制备了他克莫司的SDF,这使我们能够通过用乙醇溶胀HPMC使他克莫司完全溶解来制备他克莫司的SDF。这种新方法不需要二氯甲烷。用新方法制备的HPMC对SDF的理化性质与常规溶剂法制备的SDF相同。此外,用新方法制备的带有HPMC的SDF在40摄氏度下保存3个月后仍然稳定。两种方法制备的HPMC在SDFs之间口服后在猴子体内的药代动力学参数无显着差异(P> 0.01)。总之,我们建立了HPMC制备他克莫司SDF的新方法,这种新方法使得不用二氯甲烷即可制备他克莫司SDF成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号